vs
CRYO CELL INTERNATIONAL INC（CCEL）与Digimarc CORP（DMRC）财务数据对比。点击上方公司名可切换其他公司
Digimarc CORP的季度营收约是CRYO CELL INTERNATIONAL INC的1.1倍（$8.9M vs $7.8M），Digimarc CORP净利率更高（-47.2% vs -48.7%，领先1.4%），Digimarc CORP同比增速更快（2.9% vs -2.3%），CRYO CELL INTERNATIONAL INC自由现金流更多（$1.2M vs $895.0K），过去两年CRYO CELL INTERNATIONAL INC的营收复合增速更高（-0.1% vs -5.3%）
Cryo-Cell国际是一家脐带血库企业，由丹·理查德于1989年创立，是全球首家分离并储存干细胞的民营脐带血库，总部位于佛罗里达州奥兹马尔，地处坦帕市郊。
迪吉马克公司是一家企业软件与服务提供商，其主打产品包含带数字标识符的软件，主要用于解决防伪问题、验证产品真伪、提升回收准确性以及实现供应链可追溯，产品可广泛应用于服装、快消品、美妆健康、汽车等多个行业领域。
CCEL vs DMRC — 直观对比
营收规模更大
DMRC
是对方的1.1倍
$7.8M
营收增速更快
DMRC
高出5.1%
-2.3%
净利率更高
DMRC
高出1.4%
-48.7%
自由现金流更多
CCEL
多$318.6K
$895.0K
两年增速更快
CCEL
近两年复合增速
-5.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $7.8M | $8.9M |
| 净利润 | $-3.8M | $-4.2M |
| 毛利率 | 77.9% | 63.5% |
| 营业利润率 | -50.6% | -48.2% |
| 净利率 | -48.7% | -47.2% |
| 营收同比 | -2.3% | 2.9% |
| 净利润同比 | -105.1% | 51.4% |
| 每股收益（稀释后） | $-0.46 | $-0.18 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CCELDMRC
| Q4 25 | $7.8M | $8.9M | ||
| Q3 25 | $7.8M | $7.6M | ||
| Q2 25 | $7.9M | $8.0M | ||
| Q1 25 | $8.0M | $9.4M | ||
| Q4 24 | $8.0M | $8.7M | ||
| Q3 24 | $8.1M | $9.4M | ||
| Q2 24 | $8.0M | $10.4M | ||
| Q1 24 | $7.9M | $9.9M |
净利润CCELDMRC
| Q4 25 | $-3.8M | $-4.2M | ||
| Q3 25 | $749.4K | $-8.2M | ||
| Q2 25 | $355.8K | $-8.2M | ||
| Q1 25 | $282.9K | $-11.7M | ||
| Q4 24 | $-1.9M | $-8.6M | ||
| Q3 24 | $1.1M | $-10.8M | ||
| Q2 24 | $655.8K | $-9.3M | ||
| Q1 24 | $556.2K | $-10.3M |
毛利率CCELDMRC
| Q4 25 | 77.9% | 63.5% | ||
| Q3 25 | 77.0% | 58.3% | ||
| Q2 25 | 76.6% | 58.8% | ||
| Q1 25 | 75.1% | 65.0% | ||
| Q4 24 | 78.4% | 60.8% | ||
| Q3 24 | 73.6% | 62.4% | ||
| Q2 24 | 74.8% | 66.1% | ||
| Q1 24 | 73.7% | 62.5% |
营业利润率CCELDMRC
| Q4 25 | -50.6% | -48.2% | ||
| Q3 25 | 24.3% | -109.7% | ||
| Q2 25 | 18.8% | -105.2% | ||
| Q1 25 | 13.3% | -128.9% | ||
| Q4 24 | -1.5% | -105.1% | ||
| Q3 24 | 17.2% | -120.4% | ||
| Q2 24 | 17.3% | -96.2% | ||
| Q1 24 | 10.5% | -109.2% |
净利率CCELDMRC
| Q4 25 | -48.7% | -47.2% | ||
| Q3 25 | 9.6% | -106.9% | ||
| Q2 25 | 4.5% | -102.6% | ||
| Q1 25 | 3.5% | -125.2% | ||
| Q4 24 | -23.2% | -99.9% | ||
| Q3 24 | 13.0% | -113.9% | ||
| Q2 24 | 8.2% | -89.3% | ||
| Q1 24 | 7.1% | -104.0% |
每股收益（稀释后）CCELDMRC
| Q4 25 | $-0.46 | $-0.18 | ||
| Q3 25 | $0.09 | $-0.38 | ||
| Q2 25 | $0.04 | $-0.38 | ||
| Q1 25 | $0.03 | $-0.55 | ||
| Q4 24 | $-0.23 | $-0.40 | ||
| Q3 24 | $0.13 | $-0.50 | ||
| Q2 24 | $0.08 | $-0.43 | ||
| Q1 24 | $0.07 | $-0.50 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.3M | $12.9M |
| 总债务越低越好 | $8.4M | — |
| 股东权益账面价值 | $-18.6M | $40.2M |
| 总资产 | $61.7M | $53.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CCELDMRC
| Q4 25 | $3.3M | $12.9M | ||
| Q3 25 | $3.2M | $12.6M | ||
| Q2 25 | $4.4M | $16.1M | ||
| Q1 25 | $3.5M | $21.6M | ||
| Q4 24 | $3.5M | $28.7M | ||
| Q3 24 | $2.1M | $33.7M | ||
| Q2 24 | $1.5M | $41.5M | ||
| Q1 24 | $979.6K | $48.9M |
总债务CCELDMRC
| Q4 25 | $8.4M | — | ||
| Q3 25 | $8.4M | — | ||
| Q2 25 | $8.4M | — | ||
| Q1 25 | $8.5M | — | ||
| Q4 24 | $8.5M | — | ||
| Q3 24 | $8.5M | — | ||
| Q2 24 | $8.5M | — | ||
| Q1 24 | $8.6M | — |
股东权益CCELDMRC
| Q4 25 | $-18.6M | $40.2M | ||
| Q3 25 | $-14.8M | $41.4M | ||
| Q2 25 | $-15.6M | $46.5M | ||
| Q1 25 | $-14.7M | $50.0M | ||
| Q4 24 | $-13.2M | $61.4M | ||
| Q3 24 | $-9.6M | $70.2M | ||
| Q2 24 | $-10.7M | $77.2M | ||
| Q1 24 | $-10.3M | $84.5M |
总资产CCELDMRC
| Q4 25 | $61.7M | $53.0M | ||
| Q3 25 | $63.2M | $55.4M | ||
| Q2 25 | $64.4M | $60.7M | ||
| Q1 25 | $64.4M | $66.5M | ||
| Q4 24 | $64.7M | $75.8M | ||
| Q3 24 | $62.9M | $85.0M | ||
| Q2 24 | $62.6M | $93.4M | ||
| Q1 24 | $61.7M | $99.7M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.3M | $991.0K |
| 自由现金流经营现金流 - 资本支出 | $1.2M | $895.0K |
| 自由现金流率自由现金流/营收 | 15.5% | 10.0% |
| 资本支出强度资本支出/营收 | 0.9% | 1.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $5.2M | $-12.3M |
8季度趋势，按日历期对齐
经营现金流CCELDMRC
| Q4 25 | $1.3M | $991.0K | ||
| Q3 25 | $2.5M | $-2.6M | ||
| Q2 25 | $707.0K | $-4.7M | ||
| Q1 25 | $954.1K | $-5.5M | ||
| Q4 24 | $2.2M | $-4.2M | ||
| Q3 24 | $2.4M | $-7.1M | ||
| Q2 24 | $1.8M | $-6.8M | ||
| Q1 24 | $-356.9K | $-8.4M |
自由现金流CCELDMRC
| Q4 25 | $1.2M | $895.0K | ||
| Q3 25 | $2.5M | $-2.8M | ||
| Q2 25 | $644.6K | $-4.9M | ||
| Q1 25 | $892.0K | $-5.5M | ||
| Q4 24 | $2.1M | $-4.2M | ||
| Q3 24 | $2.3M | $-7.2M | ||
| Q2 24 | $21.5K | $-6.9M | ||
| Q1 24 | $-814.6K | $-8.5M |
自由现金流率CCELDMRC
| Q4 25 | 15.5% | 10.0% | ||
| Q3 25 | 31.9% | -36.9% | ||
| Q2 25 | 8.1% | -61.0% | ||
| Q1 25 | 11.2% | -59.1% | ||
| Q4 24 | 26.8% | -49.1% | ||
| Q3 24 | 27.9% | -75.7% | ||
| Q2 24 | 0.3% | -66.1% | ||
| Q1 24 | -10.4% | -85.8% |
资本支出强度CCELDMRC
| Q4 25 | 0.9% | 1.1% | ||
| Q3 25 | 0.5% | 2.9% | ||
| Q2 25 | 0.8% | 2.5% | ||
| Q1 25 | 0.8% | 0.6% | ||
| Q4 24 | 0.1% | 0.2% | ||
| Q3 24 | 2.3% | 0.7% | ||
| Q2 24 | 21.8% | 0.3% | ||
| Q1 24 | 5.8% | 1.1% |
现金转化率CCELDMRC
| Q4 25 | — | — | ||
| Q3 25 | 3.38× | — | ||
| Q2 25 | 1.99× | — | ||
| Q1 25 | 3.37× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.32× | — | ||
| Q2 24 | 2.70× | — | ||
| Q1 24 | -0.64× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CCEL
暂无分部数据
DMRC
| Subscription | $5.3M | 60% |
| The Government | $3.6M | 41% |
